Scientific Sessions 2025  /  Adipokine Hypothesis of Heart Failure With a Preserved Ejection Fraction  /  Adipokine Hypothesis of HFpEF
Logo

American Heart Association

  37
  0

Final ID:

Adipokine Hypothesis of HFpEF

  • Packer, Milton  ( BAYLOR HEART AND VASCULAR INSTITUTE , Dallas , Texas , United States )
    • Author Disclosures:
    Milton Packer: DO have relevant financial relationships ; Consultant:Lilly:Active (exists now) ; Consultant:v-Wave:Past (completed) ; Consultant:Noco Nordisk:Past (completed) ; Consultant:AstraZeneca:Past (completed) ; Consultant:ARMGO:Active (exists now) ; Consultant:Novartis:Past (completed) ; Consultant:Regeneron:Active (exists now) ; Consultant:Attralus:Active (exists now) ; Consultant:Biopeutics:Past (completed) ; Consultant:Salamandra:Past (completed) ; Consultant:Pharmacocosmos:Past (completed) ; Consultant:Altimmune:Active (exists now) ; Consultant:Amgen:Past (completed) ; Consultant:Abbvie:Past (completed)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Adipokine Hypothesis of Heart Failure With a Preserved Ejection Fraction

Saturday, 11/08/2025 , 01:30PM - 02:45PM

Cardiovascular Seminar

More abstracts on this topic:
Adiposity as a Predecessor to and Predictor of HFpEF

Ho Jennifer

Adiposity and Adipokines and the Comorbidites of HFpEF

Lam Carolyn, Vaduganathan Muthiah

More abstracts from these authors:
Blinded Withdrawal of Long-term Randomized Treatment with Empagliflozin or Placebo in Patients With Heart Failure

Packer Milton

Tirzepatide for Patients With Heart Failure With Preserved Ejection Fraction and Obesity: the SUMMIT Trial

Packer Milton

You have to be authorized to contact abstract author. Please, Login
Not Available